JAMA Dermatology

📄 This case report describes a man with recurrent pruritic papulovesicular eruptions who reported practicing intermittent fasting and adhering to a ketogenic diet. ja.ma/490PP7H

Short-term use of topical or systemic corticosteroids did not increase intraocular pressure (IOP) in adults with or without atopic dermatitis, supporting ocular safety during short-term treatment. ja.ma/4nnKL37

A 6-month lifestyle-focused text-messaging intervention in adults with #Psoriasis improved patient activation, diet, physical activity, and medication adherence, but did not significantly change lipid levels, glycemic control, or disease severity. ja.ma/42vHKo2

#GLP-1 receptor agonists show evidence of reducing #Psoriasis severity and systemic inflammation in patients with #obesity or #diabetes, with a favorable safety profile and compatibility with standard therapies. ja.ma/3P2u7JU

Among Boston neighborhoods, #HidradenitisSuppurativa clustered in areas with higher obesity, air pollution, heat, and proportions of Black residents, supporting a role for place-based factors in disease risk. ja.ma/4wGDa4f

Among 24,949 US patients with #Vitiligo, one-third were untreated after diagnosis and most treatments, primarily topical corticosteroids or calcineurin inhibitors, were of short duration, highlighting variable real-world management. ja.ma/4uGupVZ

Among Boston neighborhoods, #HidradenitisSuppurativa clustered in areas with higher obesity, air pollution, heat, and proportions of Black residents, supporting a role for place-based factors in disease risk. ja.ma/4w9gFoh

In PEDSnet hospitals, Black children had high #AtopicDermatitis and #HidradenitisSuppurativa frequencies yet consistently lower outpatient dermatology care use compared with other racial and ethnic groups. ja.ma/4ewdel3

📄 This case report describes a previously healthy man in his 40s who presented with a 2-day history of asymptomatic rash, prior to which he experienced fever. ja.ma/4dc3MkA

This case report describes mogamulizumab-associated Kaposi sarcoma in 2 patients with primary cutaneous T-cell lymphomas. 📄Read the full report: ja.ma/4tIhTVF

Among 24,949 US patients with #Vitiligo, one-third were untreated after diagnosis and most treatments, primarily topical corticosteroids or calcineurin inhibitors, were of short duration, highlighting variable real-world management. ja.ma/4tj1MNo

Anifrolumab treatment in #LupusErythematosus was associated with significant reductions in systemic and cutaneous disease activity, while SIGLEC-1 expression decreased alongside clinical improvement. ja.ma/3R0Gir3

In PEDSnet hospitals, Black children had high #AtopicDermatitis and #HidradenitisSuppurativa frequencies yet consistently lower outpatient dermatology care use compared with other racial and ethnic groups. ja.ma/4d6mV7v

Among displaced persons at Mexico-US border humanitarian relief camps, infectious and inflammatory skin diseases were frequently diagnosed, especially in children and areas with overcrowding. ja.ma/4t8WcNm

This Review from the @NPF Medical Board provides an evidence-informed narrative synthesis & practical considerations to introduce dermatologists to glucagon-like peptide-1 (#GLP1) receptor agonists for treatment of #psoriasis with metabolic comorbidities. ja.ma/4cYZ9eV

Biologic therapy adherence, discontinuation, and selection varied across racial and ethnic groups in Medicaid patients with #Psoriasis, pointing to disparities that affect long-term management and outcomes. ja.ma/4cZ5QMq

A man in his 50s presented with a 4-mo history of pruritic, verrucous lesions on the right lower leg. What is your diagnosis? Take the Clinical Challenge: ja.ma/4cLZ51Z

A man in his 60s undergoing #radiotherapy for prostate #cancer presented to the dermatology clinic with a 1-week history of a tender, pruritic rash to the trunk and extremities. What is your diagnosis? ja.ma/4cLvBB9

📃 This case report describes 2 patients with lichen sclerosus whose symptoms improved with glucagon-like peptide-1 receptor (#GLP-1) agonists. ja.ma/4t1tZrJ

This case report describes a woman in her 20s with hereditary leiomyomatosis and renal cell carcinoma. 📄 Read the full report: ja.ma/4w4Qpep